Endocrine changes during the perimenopause

Menopause

Volumn , Issue , 2007, Pages 67-76

  Burger, Henry G ^a   Teede, Helena J ^b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882840536     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369443-0/50007-7     Document Type: Chapter

References (72)

1. McKinlay SM, Brambilla DJ, Posner JG The normal menopause tran-sition. Maturitas 1992, 14:103-115.
2. Treloar AE Menstrual cyclicity and the premenopause. Maturitas 1981, 3:249-264.
3. Burger HG Inhibin. Reprod Med Rev 1992, 1:1-20.
4. Groome NP, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. JClin Endocrinol Metab 1996, 81:1401-1405.
5. Burger HG Clinical utility of inhibin measurements. JClin Endocrinol Metab 1993, 76:1391-1396.
6. Groome NP, Illingworth PJ, O'Brien M, et al. Detection of dimeric inhibin A throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol 1994, 40:717-723.
7. Robertson DM, Cahir N, Findlay JK, Burger HG, Groome N The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma. JClin Endocrinol Metab 1997, 82:889-896.
8. Hee J, MacNaughton J, Bangah M, et al. FSH induces dose-dependent stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle. JClin Endocrinol Metab 1993, 76:1340-1343.
9. MacNaughton J, Bangah M, McCloud PM, et al. Age related changes in follicle stimulating hormone, luteinizing hormone, estradiol and immunoreactive inhibin in women of reproductive age. Clin Endocrinol 1992, 36:339-345.
10. Burger HG, Dudley EC, Mamers P, et al. Early follicular phase serum FSH as a function of age: the roles of inhibin B, inhibin A and estradiol. Climacteric 2000, 3:17-24.
11. Corrigan AZ, Bilezikjian LM, Carroll RS, et al. Evidence for an autono-mous role of activin B within rat anterior pituitary cultures. Endocrinology 1991, 128:1682-1684.
12. Reyes FL, Winter JS, Faiman C Pituitary ovarian relationships preced-ing the menopause. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estra. Am J Obstet Gynecol 1977, 129:557-564.
13. Lee SJ, Lenton EA, Sexton L, Cooke ID The effect of age on the cyclical patterns of plasma LH, FSH, estradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1988, 3:851-855.
14. Rannevik G, Carlstrom K, Jeppsson B, et al. A prospective long-term study in women from pre-menopause to post-menopause: changing profiles of gonadotrophins, oestrogens and androgens. Maturitas 1986, 8:297-307.
15. Longcope C, Franz C, Morello C, et al. Steroid and gonadotropin levels in women during the perimenopausal years. Maturitas 1986, 8:189-196.
16. Fitzgerald CT, Self MW, Killick SR, Bennett DA Age related changes in the female reproductive cycle. Br J Obstet Gynaecol 1994, 101:229-233.
17. Brown JB, Harrisson P, Smith MA, Burger HG Correlations between the mucus symptoms and the hormonal markers of fertility throughout reproductive life 1981, Ovulation Method Research Centre of Australia, Advocate Press, Melbourne.
18. Metcalf MG, Donald RA, Livesey JH Pituitary-ovarian function in normal women during the menopausal transition. Clin Endocrinol 1981, 14:245-255.
19. Santoro N, Brown JR, Adel T, Skurnick JH Characterization of repro-ductive hormonal dynamics in the perimenopause. JClin Endocrinol Metab 1996, 81:1495-1501.
20. Metcalf MG, Donald RA Fluctuating ovarian function in a perimeno-pausal woman. NZ Med J 1979, 89:45-47.
21. Miro F, Parker SW, Aspinall LJ, et al. Relationship between folliclestimulating hormone levels at the beginning of the human menstrual cycle, length of the.
22. Miro F, Parker SW, Aspinall LJ, et al. FREEDOM study: origins and consequences of the elongation of the human menstrual cycle during the menopausal transition: the FREEDOM study JClin. Endocrinol Metab 2004, 89:4910-4915.
23. Baird DT Anovulatory dysfunctional uterine bleeding in adolescence. Adolescence in females 1985, 273-285. Year Book, Chicago. C. Flamigni, S. Venturoli, J.R. Givens (Eds.).
24. Blake EJ, Adel T, Santoro N Relationships between insulin-like growth hormone factor-1 and estradiol in reproductive aging. Fertil Steril 1997, 67:697-701.
25. Sherman BM, Korenman SG Hormonal characteristics of the human menstrual cycle throughout reproductive life. JClin Invest 1975, 55:699-706.
26. Pellicer A, Mari M, De los Santos MJ, et al. Effects of aging on the human ovary: the secretion of immunoreactive a-inhibin and proges-terone. Fertil Steril 1994, 61:663-668.
27. Hughes EG, Robertson DM, Handelsman DJ, et al. Inhibin and estra-diol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome JClin. Endocrinol Metab 1990, 70:358-364.
28. Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. JClinEndocrinol Metab 1995, 80:3537-3545.
29. Lenton EA, Kretser DM, Woodward AJ, Robertson DM Inhibin concentrations throughout the menstrual cycles of normal, infertile and older women compared with those during spontaneous conception cycles. JClin Endocrinol Metab 1991, 73:1180-1190.
30. Klein NA, Illingworth PJ, Groome NP, et al. Decreased inhibin B se-cretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric i. JClin Endocrinol Metab 1996, 81:2742-2745.
31. Welt CK, McNicholl DJ, Taylor AE, Hall JE Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999, 84:105-111.
32. Danforth DR, Arbogast LK, Mroueh J, et al. Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 1998, 70:119-123.
33. Burger HG Inhibin and steroid changes in the perimenopause. The perimenopause 1998, Springer-Verlag, New York. R. Lobo (Ed.).
34. Burger HG The physiological basis of the fertile period. Fertility and sterility 1984, 51-58. MTP Press Limited, Lancaster. R.F. Harrison, B.W. Thompson (Eds.).
35. Burger HG, Cahir N, Robertson DM, et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol 1998, 48:809-813.
36. Landgren BM, Collins A, Csemiczky G, et al. Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. JClin Endocrinol Metab 2004, 89:2763-2769.
37. Burger HG, Robertson D, Baksheev L, et al. The relationship between the endocrine characteristics and the regularity of menstrual cycles in the approach to menopause. Menopause 2005, 12:267-274.
38. Burger HG, Dudley EC, Hopper JL, et al. Prospectively measured levels of serum follicle stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-base. JClin Endocrinol Metab 1999, 84:4025-4030.
39. Block E Quantitative morphological investigations of the follicular sys-tem in women: variations in different ages. Acta Anat 1952, 14:108-123.
40. Gougeon A Caractere qualitative and quantatif de la population follicu-laire dans liavaire humain adulte. Contracept Fertil Sex 1984, 12:527-535.
41. Richardson SJ, Senikas Y, Nelson JE Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate ex-haustion. JClin Endocrinol Metab 1987, 65:1231.
42. Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992, 7:1342-1346.
43. Doring GK The incidence of anovulatory cycles in women. J Reprod Fertil 1969, 6:77-81.
44. Metcalf MG Incidence of ovulatory cycles in women approaching the menopause. J Biosoc Sci 1979, 11:39-48.
45. Vihko KK Gonadotropins and ovarian gonadotropin receptors during the perimenopausal transition period. Maturitas 1996, 2:S19-S22.
46. Van Look PF, Lothian H, Hunter WM, et al. Hypothalamic-pituitary-ovarian function in perimenopausal women. Clin Endocrinol 1977, 7:13-31.
47. Weiss G, Skurnik JH, Godsmith LT, Santoro NF, Park SJ Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA 2004, 292:2991-2996.
48. Gindoff PR, Schmidt PJ, Rubinow DR Responses to clomiphene ci-trate challenge test in normal women through perimenopause. Gynecol Obstet Invest 1997, 43:186-191.
49. Schmidt PJ, Gindoff PR, Baron DA, Rubinow DR Basal and stimu-lated gonadotropin levels in the perimenopause. Am J Obstet Gynecol 1996, 175:643-650.
50. Trévoux R, De Brux J, Castainier M, et al. Endometrium and plasma hormone profile in the peri-menopause and post-menopause. Maturitas 1986, 8:309-326.
51. Rannevik G, Jeppsson S, Johnell O, et al. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995, 21:103-113.
52. Zumoff B, Strain GW, Miller LK, Rosner W Twenty-four hour mean plasma testosterone concentration declines with age in normal pre-menopausal women. JClin Endocrinol Metab 1995, 80:1429-1430.
53. Davison SL, Bell R, Donath S, et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005, 90:3847-3853.
54. Burger HG, Dudley EC, Cui J, et al. A prospective longitudinal study of serum testosterone dehydroepiandrosterone sulfate and sex hor-mone binding globulin levels through the menopause transitio. JClin Endocrinol Metab 2000, 85:2832-2938.
55. Judd HL Hormonal dynamics associated with the menopause. Clin Obstet Gynecol 1976, 19:775-788.
56. Burger HG Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition-analysis of FSH, oestradiol and inhibin. Eur J Endocrinol 1994, 130:38-42.
57. Dennerstein L, Smith AM, Morse C, et al. Menopausal symptomatol-ogy: the experience of Australian women. Med J Aust 1993, 159:232-236.
58. Mitchell ES, Woods NF Symptom experiences of mid-life women: observations from the Seattle Midlife Women's Health Study. Maturitas 1996, 25:1-10.
59. MacGregor EA Menstruation, sex hormones and migraine. Neurol Clin 1997, 15:125-141.
60. Hunter M, Battersby R, Whitehead M Relationships between psycho-logical symptoms, somatic complaints and menopausal status. Maturitas 1986, 8:217-228.
61. Fraser IS, Baird DT Blood production and ovarian secretion rates of estradiol 17β and estrone in women with dysfunctional uterine bleed-ing. JClin Endocrinol Metab 1974, 39:564-569.
62. Abberton KM, Taylor NH, Healy DL, Rogers PA Vascular smooth muscle alpha actin distribution around endometrial arterioles during the menstrual cycle: increased expression during the perimenopause and la. Hum Reprod 1996, 11:204-211.
63. Guthrie JR, Ebeling PR, Hopper LJ, et al. A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 1998, 19:165-173.
64. Guthrie JR, Lehert P, Dennerstein L, et al. The relative effect of endog-enous estradiol and androgens on menopausal bone loss: a longitudinal study. Osteoporos int 2004, 15:881-886.
65. Nilas L, Christiansen C Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 1987, 65:697-702.
66. Steinberg RK, Freni-Titulaer W, Depuey EG, Miller DT, et al. Sex steroids and bone density in premenopausal and perimenopausal women. JClin Endocrinol Metab 1989, 69:533-539.
67. Slemenda C, Hui SL, Longcope C, Johnston CC Sex steroids and bone mass: a study of changes about the time of menopause. JClin Invest 1987, 80:1261-1269.
68. Do K-A, Green A, Guthrie J, et al. A longitudinal study of risk factors for coronary heart disease across the menopausal transition. Amer J Epidemiol 2000, 151:584-593.
69. Guthrie JR, Dennerstein L, Taffe JR, et al. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004, 7:375-389.
70. Guthrie JR, Ball M, Dudley EC, et al. Impaired fasting glycaemia in middle-aged women: a prospective study. International Journal of Obesity & Related Metabolic Disord 2001, 25:646-651.
71. Guthrie JR, Taffe JR, Lehert P, et al. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 2004, 11:315-322.
72. Guthrie JR, Dennerstein L, Taffe J, et al. Hot flushes during the meno-pause transition: a longitudinal study in Australian-born women. Menopause 2005, 12:460-467.